Research Article

Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma

Volume: 65 Number: 2 June 10, 2026
EN TR

Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma

Abstract

Aim: To compare the diagnostic performance of the MRI-based clear cell likelihood score (ccLS), radiomics-based machine learning models, and their combination for differentiating clear cell renal cell carcinoma (ccRCC) from other renal tumor subtypes. Materials and Methods: This single-center retrospective study included patients with solid renal masses who underwent multiparametric MRI and had histopathologic confirmation. Lesions were evaluated using ccLS by two independent readers. Radiomic features were extracted from T1-weighted and T2-weighted images following standardized preprocessing. Multiple machine learning pipelines combining different feature selection methods and classifiers were evaluated using stratified 10-fold cross-validation with four repetitions. Using multivariable logistic regression, the radiomics score together with clinical factors and semantic imaging features were evaluated, and a nomogram was constructed based on the selected variables. Results: For differentiating ccRCC from other renal tumor subtypes, the ccLS model achieved an area under the receiver operating characteristic curve (AUC) of 0.832 (0.759–0.899). The best-performing radiomics-based machine learning model achieved a mean AUC of 0.89 ± 0.10. The combined model demonstrated higher diagnostic performance, with a mean AUC of 0.96 ± 0.01. Conclusions: Combining radiomics-based machine learning with established semantic MRI assessments was associated with improved differentiation of ccRCC from other renal tumor subtypes compared with individual approaches. Further validation in larger, multicenter cohorts is warranted before broader clinical application.

Keywords

Ethical Statement

This single-center retrospective study was conducted following approval from the Ege University Medical Research Ethics Committee (approval date: November 30, 2023; decision no: 23-11.2T/8).

References

  1. May AM, Guduru A, Fernelius J, Raza SJ, et al. Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass. Kidney Cancer 2019;3:183–88.
  2. Remzi M, Özsoy M, Klingler H-C, et al. Are Small Renal Tumors Harmless? Analysis of Histopathological Features According to Tumors 4 Cm or Less in Diameter. J Urol 2006;176(3):896-99.
  3. Finelli A, Cheung DC, Al-Matar A, et al. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. Eur Urol. 2020;78:460–67.
  4. Pedrosa I. Invited Commentary: MRI Clear Cell Likelihood Score for Indeterminate Solid Renal Masses: Is There a Path for Broad Clinical Adoption? RadioGraphics 2023;43(7):e230042.
  5. Zhong J, Hu Y, Xing Y, et al. Is there enough evidence supporting the clinical adoption of clear cell likelihood score (ccLS)? An updated systematic review and meta-analysis. Insights Imaging 2024;15(1):242.
  6. Shetty AS, Fraum TJ, Ballard DH, et al. Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User’s Guide. RadioGraphics 2023;43(7):e220209.
  7. Suarez-Ibarrola R, Hein S, Reis G, Gratzke C, Miernik A. Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer. World J Urol 2020;38:2329–47.
  8. Matsumoto S, Arita Y, Yoshida S, et al. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdom Radiol (NY) 2022;47:2178–86.

Details

Primary Language

English

Subjects

Radiology and Organ Imaging

Journal Section

Research Article

Publication Date

June 10, 2026

Submission Date

February 4, 2026

Acceptance Date

March 2, 2026

Published in Issue

Year 2026 Volume: 65 Number: 2

APA
Karabulut, A. K., Koska, İ. Ö., Turgut, A. Ç., Sarsik Kumbaraci, B., Kızılay, F., & Güler, E. (2026). Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma. Ege Tıp Dergisi, 65(2), 313-320. https://doi.org/10.19161/etd.1882022
AMA
1.Karabulut AK, Koska İÖ, Turgut AÇ, Sarsik Kumbaraci B, Kızılay F, Güler E. Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma. EJM. 2026;65(2):313-320. doi:10.19161/etd.1882022
Chicago
Karabulut, Ahmet Kasım, İlker Özgür Koska, Ali Çağlar Turgut, Banu Sarsik Kumbaraci, Fuat Kızılay, and Ezgi Güler. 2026. “Integration of Radiomics With MRI Clear Cell Likelihood Score for Classification of Clear Cell Renal Cell Carcinoma”. Ege Tıp Dergisi 65 (2): 313-20. https://doi.org/10.19161/etd.1882022.
EndNote
Karabulut AK, Koska İÖ, Turgut AÇ, Sarsik Kumbaraci B, Kızılay F, Güler E (June 1, 2026) Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma. Ege Tıp Dergisi 65 2 313–320.
IEEE
[1]A. K. Karabulut, İ. Ö. Koska, A. Ç. Turgut, B. Sarsik Kumbaraci, F. Kızılay, and E. Güler, “Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma”, EJM, vol. 65, no. 2, pp. 313–320, June 2026, doi: 10.19161/etd.1882022.
ISNAD
Karabulut, Ahmet Kasım - Koska, İlker Özgür - Turgut, Ali Çağlar - Sarsik Kumbaraci, Banu - Kızılay, Fuat - Güler, Ezgi. “Integration of Radiomics With MRI Clear Cell Likelihood Score for Classification of Clear Cell Renal Cell Carcinoma”. Ege Tıp Dergisi 65/2 (June 1, 2026): 313-320. https://doi.org/10.19161/etd.1882022.
JAMA
1.Karabulut AK, Koska İÖ, Turgut AÇ, Sarsik Kumbaraci B, Kızılay F, Güler E. Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma. EJM. 2026;65:313–320.
MLA
Karabulut, Ahmet Kasım, et al. “Integration of Radiomics With MRI Clear Cell Likelihood Score for Classification of Clear Cell Renal Cell Carcinoma”. Ege Tıp Dergisi, vol. 65, no. 2, June 2026, pp. 313-20, doi:10.19161/etd.1882022.
Vancouver
1.Ahmet Kasım Karabulut, İlker Özgür Koska, Ali Çağlar Turgut, Banu Sarsik Kumbaraci, Fuat Kızılay, Ezgi Güler. Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma. EJM. 2026 Jun. 1;65(2):313-20. doi:10.19161/etd.1882022

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.